Uddannelses- og Forskningsudvalget 2015-16
UFU Alm.del Bilag 116
Offentligt
1610627_0001.png
Danish Parliamentary Visit
26 January 2016
Dr Tony Raven, Chief Executive,
Cambridge Enterprise Limited, University of Cambridge
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0002.png
The University’s Mission
The mission of the University of Cambridge
is
to contribute to society
through the pursuit of
education, learning, and research at the
highest international levels of excellence.
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0003.png
Cambridge Enterprise’s Mission
The objectives of CE Limited are, in order of precedence,
to
aid the transfer of knowledge from the University via
commercialisation;
aid staff and students in making their ideas more
commercially successful; and
produce a financial return for inventors, departments
and the University.
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0004.png
Innovation is in the University’s DNA
Cambridge University
Press: 1534
Cambridge
Instruments: 1881
Pye: 1896
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0005.png
Cambridge changing the world of health
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0006.png
Cambridge changing the World of IT
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0007.png
Leading to Europe’s most successful technology
cluster.
?
2x $10Bn
companies
14x $1Bn
companies
A vibrant
Cambridge Cluster
Economy
World leading
underpinning
science
19 science parks, 1,525 cluster companies
57,000 employees £13Bn+ t/o
Whittle Turing Darwin Watson & Crick
Babbage
Rutherford
Sanger…
92 Nobel Prize Winners &
Oscar
1
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0008.png
MIT Survey of Global Expert Opinion
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0009.png
MIT Survey of Global Expert Opinion
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0010.png
Chancellor of the Exchequer’s speech on science in
Cambridge, 25 April 2014
“This
support for and application of science is right
at the centre of our long term economic plan.
You are testament to the world leading science and
innovation that we have in Britain.
Ideas developed here, commercialised here, and
now at the centre of Britain’s industrial recovery.
It’s an extraordinary story –
and I know that with the
right support from government, you can do even
more. So
I’m here to tell you: we will continue to
back Cambridge.”
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0011.png
The Cambridge model
Recruit the best academics in the world
Give them the freedom to do what they choose.
IP belongs to the University unless requested by the academics
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0012.png
Intellectual Property
Intellectual Property
Evolutionary
Industry
Incumbents
Tacit
Consultancy
Policy
Disruptive
Mavericks
Supporting
Existing
Industries
Licensing
Research Collaborations
Creating
New
Industries
Spin Outs
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0013.png
Cambridge Enterprise
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0014.png
XO1
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0015.png
Deradicalising religious youth
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0016.png
Saving the Olympics!
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0017.png
Some comments on university technology transfer
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0018.png
Don’t copy Cambridge
Cambridge works in Cambridge
Other places have:
Different cultures
Different environments
Different legal and regulatory constraints
Different resources
Different objective
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0019.png
Our driver is societal benefit
CE costs ~£2.5m p.a. to run
“financial
contributions of patent licensing to most university operating
budgets are modest at best, and negative for a great many
institutions”
1
Only 15% of US university TTOs break-even or better
The 15% are generally in a serendipitous big win
Stanford OTL is currently wrestling with the end of its recombinant DNA patent royalties which are
60% of their total license income
But there is a high economic return on investment
2
Average across England for HEIF is 7.3x monetised and 2.4x non-monetised
Top six are 22.5x, bottom one is 1.5x
America’s research enterprise,
US National Academies (2014).
1
Furthering
2
HEFCE:
Assessing the Economic Impacts of the Higher Education Innovation Fund (2015)
37
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0020.png
It takes time……..
Income vs Age of IP
Cambridge
90%
80%
University of California
60%
50%
40%
30%
20%
10%
0%
70%
60%
50%
40%
30%
20%
10%
0%
0-5yrs
5-10yrs
>10yrs
0-10yrs
10-20yrs
>20yrs
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0021.png
The SME question
There are 5 million SMEs in the UK
There are 200 thousand academics (25:1)
The UK universities can probably support 10-20 thousand SMEs
Therefore >99% are going to be disappointed.
The question therefore is not how we work with more SMEs but what
identifies the small number of SMEs we should be working with
The Cambridge cluster has over 1,500 high tech SMEs
We touch a small number through research
We touch a large number through graduate/PG employment and the
environment.
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0022.png
Are Universities difficult to work with?
Many anecdotes but little evidence.
Many issues central to a university are not familiar to many companies
Charities Act
State Aid
Freedom to carry on core business of research and teaching
Diligence provisions
Cannot warrant outcomes of research
Many companies do not typically have
the depth of experience of TTO’s –
one or two licenses/spin outs
p.a. vs
100’s
Lambert (standardised) Agreements
The activity is complex
many diverse and different drivers.
In a recent survey of business perceptions of Cambridge, Oxford and Imperial, “difficult to work with”
was the least cited characteristic (3% of responses)
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0023.png
Do we need a TTO?
Most jobs would still need to be done by someone
:
Advise academics
Identify and protect IP
Check freedoms to operate
Check contractual constraints
Check export control restrictions
Actively market the technology (to industry or investors)
Select licensee(s)/build business plan and investor syndicate
Negotiate license or investment terms
Audit licenses
Collection and distribution of revenues
Supporting translational funding
MRC-Confidence in Concept, Wellcome Seeding Drug Discovery,
………..
Some academics have the necessary experience, most do not
Many opportunities are too early/too different for industry
Many opportunities are social rather than financial esp. in AHSS and not
going to be supported by industry or investors
UFU, Alm.del - 2015-16 - Bilag 116: Præsentationsmaterialer fra England
1610627_0024.png
Thank you & questions.
[email protected]
www.enterprise.cam.ac.uk